Staff

Pharnext Announces First Patient Enrolled in the PREMIER Trial, its Pivotal Phase III Clinical Development Program of PXT3003 in Charcot-Marie-Tooth Disease Type 1A (‘CMT1A’)

From Weeks to Same Day: NeuGen and PatientPing Partnership Enables Faster Transitions of Care and COVID-19 Identification Rates for Wisconsin Members

BOSTON, March 30, 2021 /PRNewswire/ -- PatientPing, the nation's leading care collaboration platform, and NeuGen, a Shared Services organization providing support...

error: Content is protected !!